Cleared Traditional

K013963 - MODEL 9210 DELIVERY CATHETER

K013963 is the FDA 510(k) clearance for MODEL 9210 DELIVERY CATHETER by Medtronic Vascular. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 87-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2002
Decision
87d
Days
Class 2
Risk

K013963 is an FDA 510(k) clearance for the MODEL 9210 DELIVERY CATHETER, MODEL 9210. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Medtronic Vascular (Minneapolis, US). The FDA issued a Cleared decision on February 28, 2002 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic Vascular devices

Submission Details

510(k) Number K013963 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 2001
Decision Date February 28, 2002
Days to Decision 87 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 125d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 590
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K013963.
RADIAL ARTERY CATHERIZATION SET WITH INTEGRAL NEEDLE PROTECTION,MODEL RA-04020-SP
K021120 · Arrow Intl., Inc. · May 2002
EASYTRAK GUIDING CATHETER
K021284 · Guidant Corp. · May 2002
10600 DEFLECTABLE CATHETER SYSTEM, MODEL 10600
K013517 · Medtronic Vascular · Apr 2002
AGILTRAC .018 PERIPHERAL DILATATION CATHETER
K020161 · Guidant Corp. · Feb 2002
6F MACH1/34356-XXX
K020028 · Boston Scientific · Jan 2002
BARD CONQUEST PTA BALLOON DILATATION CATHETER
K014212 · C.R. Bard, Inc. · Jan 2002